These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32298302)

  • 1. Treatment of mice with a ligand binding blocking anti-CD28 monoclonal antibody improves healing after myocardial infarction.
    Gladow N; Hollmann C; Ramos G; Frantz S; Kerkau T; Beyersdorf N; Hofmann U
    PLoS One; 2020; 15(4):e0227734. PubMed ID: 32298302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation.
    Weirather J; Hofmann UD; Beyersdorf N; Ramos GC; Vogel B; Frey A; Ertl G; Kerkau T; Frantz S
    Circ Res; 2014 Jun; 115(1):55-67. PubMed ID: 24786398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpastatin overexpression impairs postinfarct scar healing in mice by compromising reparative immune cell recruitment and activation.
    Wan F; Letavernier E; Le Saux CJ; Houssaini A; Abid S; Czibik G; Sawaki D; Marcos E; Dubois-Rande JL; Baud L; Adnot S; Derumeaux G; Gellen B
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1883-93. PubMed ID: 26453333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice.
    Hofmann U; Beyersdorf N; Weirather J; Podolskaya A; Bauersachs J; Ertl G; Kerkau T; Frantz S
    Circulation; 2012 Apr; 125(13):1652-63. PubMed ID: 22388323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Aryl Hydrocarbon Receptor by ITE Improves Cardiac Function in Mice After Myocardial Infarction.
    Seong E; Lee JH; Lim S; Park EH; Kim E; Kim CW; Lee E; Oh GC; Choo EH; Hwang BH; Kim CJ; Ihm SH; Youn HJ; Chung WS; Chang K
    J Am Heart Assoc; 2021 Jul; 10(13):e020502. PubMed ID: 34157850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2/Anti-Interleukin-2 Immune Complex Attenuates Cardiac Remodeling after Myocardial Infarction through Expansion of Regulatory T Cells.
    Zeng Z; Yu K; Chen L; Li W; Xiao H; Huang Z
    J Immunol Res; 2016; 2016():8493767. PubMed ID: 27144181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.
    Graves SS; Stone DM; Loretz C; Peterson LJ; Lesnikova M; Hwang B; Georges GE; Nash R; Storb R
    Transplantation; 2011 Apr; 91(8):833-40. PubMed ID: 21343872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28 Costimulation of T Helper 1 Cells Enhances Cytokine Release
    Langenhorst D; Haack S; Göb S; Uri A; Lühder F; Vanhove B; Hünig T; Beyersdorf N
    Front Immunol; 2018; 9():1060. PubMed ID: 29868020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes derived from dendritic cells improve cardiac function via activation of CD4(+) T lymphocytes after myocardial infarction.
    Liu H; Gao W; Yuan J; Wu C; Yao K; Zhang L; Ma L; Zhu J; Zou Y; Ge J
    J Mol Cell Cardiol; 2016 Feb; 91():123-33. PubMed ID: 26746143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody.
    Beyersdorf N; Ding X; Blank G; Dennehy KM; Kerkau T; Hünig T
    Blood; 2008 Nov; 112(10):4328-36. PubMed ID: 18780833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infarcted Myocardium-Primed Dendritic Cells Improve Remodeling and Cardiac Function After Myocardial Infarction by Modulating the Regulatory T Cell and Macrophage Polarization.
    Choo EH; Lee JH; Park EH; Park HE; Jung NC; Kim TH; Koh YS; Kim E; Seung KB; Park C; Hong KS; Kang K; Song JY; Seo HG; Lim DS; Chang K
    Circulation; 2017 Apr; 135(15):1444-1457. PubMed ID: 28174192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic
    Zaidi Y; Corker A; Vasileva VY; Oviedo K; Graham C; Wilson K; Martino J; Troncoso M; Broughton P; Ilatovskaya DV; Lindsey ML; DeLeon-Pennell KY
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H948-H962. PubMed ID: 34597184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 confers CD4+ T cells with resistance to cyclosporin A and tacrolimus but to different degrees.
    Kawai H; Yagyu F; Terada A; Matsunaga T; Inobe M
    Asian Pac J Allergy Immunol; 2024 Sep; 42(3):298-304. PubMed ID: 33638630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocytes prime autoreactive T cells after myocardial infarction.
    DeBerge M; Yu S; Dehn S; Ifergan I; Yeap XY; Filipp M; Becker A; Luo X; Miller S; Thorp EB
    Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H116-H123. PubMed ID: 31809213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
    Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
    Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28-specific antibody prevents graft-versus-host disease in mice.
    Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
    J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.